SciNeuro

company

About

SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$100M
Industries
Biopharma,Biotechnology,Neuroscience
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100M
SciNeuro has raised a total of $100M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2020 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2020 Series A $100M 2 ARCH Venture Partners
Lilly Asia Ventures
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
SciNeuro is funded by 2 investors. ARCH Venture Partners and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Series A
Lilly Asia Ventures Yes Series A